News

Read the latest updates about BioMarin and learn more about our science, our people and the communities we support.

Chieze Ibeneche-Nnewihe

Chieze Ibeneche-Nnewihe Reflects on Her Journey from Amateur Scientist to Business Development Leader

February 18, 2026

Christine O'Brien and her family

Community

‘We’re Fighters’: How One Family is Advocating for Progress in ENPP1 Deficiency

February 1, 2026

Donnie Mackenzie

Donnie Mackenzie: Rising to the Challenge to Deliver Transformative Therapies

January 5, 2026

Stories

All Stories

Chieze Ibeneche-Nnewihe

Chieze Ibeneche-Nnewihe Reflects on Her Journey from Amateur Scientist to Business Development Leader

February 18, 2026

Christine O'Brien and her family

Community

‘We’re Fighters’: How One Family is Advocating for Progress in ENPP1 Deficiency

February 1, 2026

DNA of BioMarin Andrew Melton

Finding His Rhythm in Science: Andrew’s Journey to Bioanalytical Sciences Leadership

January 26, 2026

Donnie Mackenzie

Donnie Mackenzie: Rising to the Challenge to Deliver Transformative Therapies

January 5, 2026

Marie Josee Toutounji

People and Culture

A Family Legacy: Marie-Josee Toutounji Following in Her Parents’ Footsteps

December 22, 2025

Joyanna Hansen

Joyanna Hansen: A Journey from the Clinic to BioMarin

December 2, 2025

Press Releases

All Press Releases

U.S. Food and Drug Administration Approves BioMarin’s PALYNZIQ® (pegvaliase-pqpz) for Adolescents 12 Years of Age and Older with Phenylketonuria (PKU)

February 27, 2026

BioMarin to Participate in Four Upcoming Investor Conferences in March

February 24, 2026

BioMarin Reports Fourth Quarter and Full-year 2025 Financial and Operating Results

February 23, 2026

BioMarin to Host Fourth Quarter and Full-Year 2025 Financial Results Conference Call and Webcast on Monday, February 23, 2026, at 4:30pm ET

February 17, 2026

BioMarin Announces Closing of Private Offering of Senior Notes

February 12, 2026

Company Statements

All Company Statements